Correlation Between Kymera Therapeutics and Generation Bio

Can any of the company-specific risk be diversified away by investing in both Kymera Therapeutics and Generation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kymera Therapeutics and Generation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kymera Therapeutics and Generation Bio Co, you can compare the effects of market volatilities on Kymera Therapeutics and Generation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kymera Therapeutics with a short position of Generation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kymera Therapeutics and Generation Bio.

Diversification Opportunities for Kymera Therapeutics and Generation Bio

0.89

Correlation Coefficient

Kymera Therapeutics  Generation Bio

Very poor diversification

The 3 months correlation between Kymera and Generation is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Kymera Therapeutics and Generation Bio Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generation Bio and Kymera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kymera Therapeutics are associated (or correlated) with Generation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generation Bio has no effect on the direction of Kymera Therapeutics i.e., Kymera Therapeutics and Generation Bio go up and down completely randomly.

Pair Corralation between Kymera Therapeutics and Generation Bio

Given the investment horizon of 90 days Kymera Therapeutics is expected to generate 0.8 times more return on investment than Generation Bio. However, Kymera Therapeutics is 1.25 times less risky than Generation Bio. It trades about -0.24 of its potential returns per unit of risk. Generation Bio Co is currently generating about -0.32 per unit of risk. If you would invest  3,849  in Kymera Therapeutics on December 5, 2024 and sell it today you would lose (768.00) from holding Kymera Therapeutics or give up 19.95% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Kymera Therapeutics  vs.  Generation Bio Co

Kymera Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kymera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Generation Bio

Risk-Adjusted Performance

Very Weak

Over the last 90 days Generation Bio Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Kymera Therapeutics and Generation Bio

The main advantage of trading using opposite Kymera Therapeutics and Generation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kymera Therapeutics position performs unexpectedly, Generation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will offset losses from the drop in Generation Bio's long position.

The idea behind Kymera Therapeutics and Generation Bio Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.